Skip to content

Macimorelin Research

Peer-reviewed studies from PubMed on Macimorelin mechanisms, clinical trials, and safety data. 43 total studies indexed.

Research Overview

43Total studies
1Human trials
0Systematic reviews
0Animal studies
◐ Moderate EvidenceEvidence level
20202026Date range
PloS onePMID: 41604371

Colorectal cancer is characterized by various oncogenic mutations, with the KRAS G12D mutation being the most prevalent. The development of MRTX1133 has revitalized the KRAS direct targeting. However, colorectal cancer demonstrated intrinsic resistance to MRTX1133, primarily due to the feedback a...

View on PubMed
Acta pharmacologica SinicaPMID: 40542284

The growth hormone secretagogue receptor (GHSR) plays a critical role in regulating growth hormone release and metabolic homeostasis. Understanding the molecular mechanisms of ligand-GHSR recognition is essential for developing therapeutic interventions. In this study, we investigated the molecul...

View on PubMed
PituitaryPMID: 40335774

Biochemical tests are required for diagnosing GH-deficiency in children and adults, but controversies remain regarding diagnostic criteria and type of biochemical tests. The aim of the study is to map the clinical practices of GHD diagnosis in children and adults.The Growth Hormone Research Socie...

View on PubMed
BiomoleculesPMID: 38927114

Incidences of drug-resistant tuberculosis have become common and are rising at an alarming rate. Aminoacyl t-RNA synthetase has been validated as a newer target against Mycobacterium tuberculosis. Leucyl t-RNA synthetase (LeuRS) is ubiquitously found in all organisms and regulates transcription, ...

View on PubMed
Journal of endocrinological investigationPMID: 38461479

The clinical features of adult GH deficiency (GHD) are nonspecific, and its diagnosis is established through GH stimulation testing, which is often complex, expensive, time-consuming and may be associated with adverse side effects. Moreover, diagnosing adult GHD can be challenging due to the infl...

View on PubMed
Reviews in endocrine & metabolic disordersPMID: 38087160

Arginine vasopressin deficiency (AVP-D) is one of the main entities of the polyuria-polydipsia syndrome. Its correct diagnosis and differentiation from the other two causes - AVP resistance and primary polydipsia - is crucial as this determines the further management of these patients.Over the la...

View on PubMed
Diagnostics (Basel, Switzerland)PMID: 37443653

Genetic tests have led to the discovery of many novel genetic variants related to growth failure, but the clinical significance of some results is not always easy to establish. The aim of this report is to describe both clinical phenotype and genetic characteristics in an adult patient with short...

View on PubMed
Endocrine connectionsPMID: 37052176

Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the si...

View on PubMed
Journal of cachexia, sarcopenia and musclePMID: 36860137

Cancer cachexia is associated with reduced body weight, appetite and quality of life (QOL) with no approved treatments. Growth hormone secretagogues like macimorelin have potential to mitigate these effects.This pilot study assessed the safety and efficacy of macimorelin for 1 week. Efficacy...

View on PubMed
PituitaryPMID: 35723775

Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not macimorelin, stimulated copeptin secretion (a surrogate marker of vasopressin) and, therefore, provide novel test...

View on PubMed
Hormone research in paediatricsPMID: 34438400

Diagnosis of growth hormone deficiency (GHD) in children requires the use of provocative growth hormone (GH) stimulation tests, which can have limited reliability and are potentially contraindicated in some patients. This is the first paediatric study to test the safety, tolerability, and pharmac...

View on PubMed
European journal of endocrinologyPMID: 34181566

Oxytocin, secreted into circulation through the posterior pituitary, regulates lactation, weight, and socio-behavioral functioning. Oxytocin deficiency has been suggested in patients with hypopituitarism; however, diagnostic testing for oxytocin deficiency has not been developed. The aim of this ...

View on PubMed
European journal of neurologyPMID: 34157194

Current drugs for epilepsy affect seizures, but no antiepileptogenic or disease-modifying drugs are available that prevent or slow down epileptogenesis, which is characterized by neuronal cell loss, inflammation and aberrant network formation. Ghrelin and ghrelin receptor (ghrelin-R) agonists wer...

View on PubMed
PituitaryPMID: 33615399

The test with the highest diagnostic accuracy for diabetes insipidus is copeptin measurement after hypertonic saline infusion. However, the procedure is cumbersome and unpleasant due to rapid sodium increase. An oral stimulation test would be highly desirable. Macimorelin, an oral ghrelin agonist...

View on PubMed
Biomedical chromatography : BMCPMID: 33458843

Analytical methods to determine the potential misuse of the ghrelin mimetics capromorelin (CP-424,391), macimorelin (macrilen, EP-01572) and tabimorelin (NN703) in sports were developed. Therefore, different extraction strategies, i.e. solid-phase extraction, protein precipitation, as well as a "...

View on PubMed
Endocrine connectionsPMID: 33320108

The macimorelin test is approved for the diagnosis of adult growth hormone deficiency (AGHD) based on its efficacy vs the insulin tolerance test (ITT). Macimorelin has a significant advantage over ITT in avoiding hypoglycemia. Analyses were conducted to determine whether macimorelin performance i...

View on PubMed
Best practice & research. Clinical endocrinology & metabolismPMID: 33272904

Growth hormone deficiency (GHD) generally occurs in patients with Cushing's disease (CD) as a consequence of cortisol excess. Mass effect may contribute to the development of GHD in the minority of patients with CD due to corticotroph macroadenomas. Patients with CD in remission are at considerab...

View on PubMed
Clinical pharmacology in drug developmentPMID: 32961034

Macimorelin is an orally active growth hormone secretagogue indicated for the diagnosis of adult growth hormone deficiency. The primary objective of this study was to evaluate the effect of macimorelin on the baseline and placebo-corrected mean QT interval using Fridericia's formula (Δ&#x39...

View on PubMed

Disclaimer: This page aggregates research from PubMed for educational purposes only. Inclusion of a study does not imply endorsement of its findings. Always consult a qualified healthcare professional before making decisions based on research literature.